Fenfluramine HCl not checked

UCB BIOSCIENCES, Inc. · ZX0008 · ZX008

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 3 trial completes
Trials
2 active
4 in total · 3 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Rett Syndrome
Main trialPhase 3
“The purpose of this study is to investigate the efficacy of fenfluramine hydrochloride (HCl) versus placebo in study participants with Rett syndrome (RTT).”In the company’s words, NCT07503444 on ClinicalTrials.gov
Other names
Fintepla · ZX0008 · fenfluramine · fenfluramine hydrochloride · ZX008

Other drugs for Rett Syndrome

All 5 drugs for Rett Syndrome

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 6 Feb 2029 A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
Phase 3Completed 1 Sep 2026 A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome
Phase 1Completed 12 Jun 2025 A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants
Phase 2Authorised not given Open label extension study for monitoring long-term safety in patients with Myoclonic Astatic Epilepsy (Doose-Syndrome) receiving Fenfluramine as add-on therapy
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Fenfluramine HCl

Following is part of Solo: you see every change to Fenfluramine HCl the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in